Brief: Candel Therapeutics Appoints Charles Schoch As Chief Financial Officer
23/06/2025 13:20
June 23 (Reuters) - Candel Therapeutics Inc CADL.O: CANDEL THERAPEUTICS APPOINTS CHARLES SCHOCH AS CHIEF FINANCIAL OFFICER Source text: ID:nGNX99lG2p Further company coverage: CADL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Candel Therapeutics
See all newsBrief: Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints In Patients From Phase 3 Trial Of Aglatimagene Besadenovec (Can-2409)
Candel Therapeutics reports Q1 loss
Brief: Candel Therapeutics Q1 Net Income USD -8.861 Million
Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Candel Therapeutics Inc Extended Survival Tail Observed In Trial Of Aglatimagene Besadenovec